Eddy Edson
Well-Known Member
- Relationship to Diabetes
- In remission from Type 2
Presented at EASD conference in Stockholm yesterday.
Confirming the prelim results from earlier this year: normal-weight T2D's achieve weight-loss driven remission at about the same rate as overweight/obese T2D's. (But the avg amount of weight loss required is lower: ~8% of body weight vs ~15%.)
Slides:
DUK story: https://www.diabetes.org.uk/about_us/news/our-research-easd
After 12 months, the findings showed that:
Participants’ BMI averaged 22.4 kg/m² at the end of the study (reduced from an average of 24.8 kg/m²).
About three quarters (70%) of participants went into remission from type 2 diabetes during the study, with 50% of these going into remission after the first weight loss cycle.
People needed to lose on average 8% of their body weight to go into remission.
In the 14 out of 20 people who went into remission, their average HbA1c fell from 53mmol/mol at the start of the study to 45mmol/mol. Their blood pressure dropped despite taking less medication to treat this.
The participants’ liver and pancreas fat levels were higher than expected at the start of the trial but then decreased to normal levels after weight loss.
Chris Askew, Chief Executive of Diabetes UK, said:
“Building on the pioneering DiRECT trial, this game-changing study from Professor Taylor and his team advances our understanding of why type 2 diabetes develops, and what can be done to treat it.
“Our ambition is for as many people as possible to have the chance to put their type 2 diabetes into remission and live well for longer. The findings of the ReTUNE study potentially take us a significant step closer to achieving this goal by showing that remission isn’t only possible for people of certain body weights.
“It is our hope that ReTUNE – as DiRECT did before it – will inform the development of services and support so that many more people with type 2 diabetes will have the possibility of remission open to them."
Confirming the prelim results from earlier this year: normal-weight T2D's achieve weight-loss driven remission at about the same rate as overweight/obese T2D's. (But the avg amount of weight loss required is lower: ~8% of body weight vs ~15%.)
Slides:
DUK story: https://www.diabetes.org.uk/about_us/news/our-research-easd
After 12 months, the findings showed that:
Participants’ BMI averaged 22.4 kg/m² at the end of the study (reduced from an average of 24.8 kg/m²).
About three quarters (70%) of participants went into remission from type 2 diabetes during the study, with 50% of these going into remission after the first weight loss cycle.
People needed to lose on average 8% of their body weight to go into remission.
In the 14 out of 20 people who went into remission, their average HbA1c fell from 53mmol/mol at the start of the study to 45mmol/mol. Their blood pressure dropped despite taking less medication to treat this.
The participants’ liver and pancreas fat levels were higher than expected at the start of the trial but then decreased to normal levels after weight loss.
Chris Askew, Chief Executive of Diabetes UK, said:
“Building on the pioneering DiRECT trial, this game-changing study from Professor Taylor and his team advances our understanding of why type 2 diabetes develops, and what can be done to treat it.
“Our ambition is for as many people as possible to have the chance to put their type 2 diabetes into remission and live well for longer. The findings of the ReTUNE study potentially take us a significant step closer to achieving this goal by showing that remission isn’t only possible for people of certain body weights.
“It is our hope that ReTUNE – as DiRECT did before it – will inform the development of services and support so that many more people with type 2 diabetes will have the possibility of remission open to them."
Last edited: